Target intelligence / Profile preview

Sodium-activated potassium channel subunit KNa1.1 (KCNT1)

Target
KCNT1
Molecular classification
Ion channel, Potassium channel, Sodium-activated potassium channel, Voltage-dependent channel (distinct from classical voltage-sensing channels)
01

Overview

The Slack potassium channel (KCNT1, KNa1.1, Slo2.2) is a large, sodium-activated potassium channel highly expressed in neurons throughout the brain. Its structure includes six transmembrane domains per subunit and a very large cytoplasmic C-terminal tail containing two regulator of conductance of potassium (RCK) domains. Slack channels are crucial for modulating neuronal action potential firing, burst firing, and overall membrane excitability. They are distinct from classical voltage-gated potassium channels: Slack channels are activated by intracellular sodium rather than changes in voltage, and they are insensitive to calcium. Pathogenic variants in KCNT1 are associated with early-onset epileptic syndromes and intellectual disability, underlining their significance in higher brain functions and neurodevelopmental disease. Experimentally, Slack channels interact with proteins such as Fragile X mental retardation protein, suggesting a role in diseases like Fragile X syndrome and autism. Therapeutic strategies are emerging, focusing on channel inhibition or knockdown using antisense technologies, but selective, safe drugs remain a challenge due to the risk of off-target effects and adverse cardiac outcomes.

Other names
SlackSlo2.2KCNT1KNa1.1sodium-activated potassium channel
02

Mechanism of action

Channel inhibition (by molecules such as quinidine, blocking excessive channel activity caused by gain-of-function mutations) Reduction of KCNT1 expression (via antisense oligonucleotides)

03

Biological functions

Regulation of neuronal excitabilityModulation of firing patterns and burst firing in neuronsAdaptation of firing rateContribution to resting membrane potentialSignal transductionInvolvement in cognitive flexibility and spatial learning
04

Disease associations

Epilepsy (particularly KCNT1 epileptic syndromes, such as epilepsy of infancy with migrating focal seizures—EIMFS)Intellectual disabilityAutism spectrum disorders (via interaction with Fragile X mental retardation protein)Other neurodevelopmental disorders
05

Safety considerations

Off-target effects and low specificity of available drugs (e.g., quinidine can affect cardiac function)Risk of cardiac arrhythmias when using some channel blockers (quinidine)Therapeutic challenges include targeting brain-specific Slack channels without affecting peripheral potassium channels
06

Interacting drugs

Quinidine

2 more in the full profile.

07

Biomarkers

Gain-of-function mutations in KCNT1 gene for patient selection in epilepsy studiesProtein expression (KCNT1) may serve as a biomarker in specific research/diagnostic contextsNo widely accepted circulating or tissue biomarker for efficacy monitoring at the current state of research

Beyond the preview

Go deeper on Sodium-activated potassium channel subunit KNa1.1 (KCNT1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sodium-activated potassium channel subunit KNa1.1 (KCNT1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call